GP 1a

CAS No. 511532-96-0

GP 1a( —— )

Catalog No. M35265 CAS No. 511532-96-0

GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 78 Get Quote
5MG 107 Get Quote
10MG 169 Get Quote
25MG 330 Get Quote
50MG 490 Get Quote
100MG 683 Get Quote
500MG 1377 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GP 1a
  • Note
    Research use only, not for human use.
  • Brief Description
    GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays.
  • Description
    GP1a is a potent agonist of cannabinoid receptor 2 (CB2). Gp1a is beneficial to skin wound healing. GP1a inhibits inflammation and fibrogenesis while promoting re-epithelialization.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor | PERK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    511532-96-0
  • Formula Weight
    441.35
  • Molecular Formula
    C23H22Cl2N4O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (283.22 mM; Ultrasonic )
  • SMILES
    C(NN1CCCCC1)(=O)C=2C3=C(N(N2)C4=C(Cl)C=C(Cl)C=C4)C=5C(C3)=CC(C)=CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao C, et al. An enzyme-responsive Gp1a-hydrogel for skin wound healing. J Biomater Appl. 2021;36(4):714-721.?
molnova catalog
related products
  • Cannabichromene

    Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).

  • RVD-Hpα

    N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. Also high affinity CB2 positive allosteric modulator (Ki = 50 nM).

  • NESS-0327

    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.